GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Other Long Term Assets

Chongqing Lummy Pharmaceutical (SZSE:300006) Other Long Term Assets : ¥669.4 Mil (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Other Long Term Assets?

Chongqing Lummy Pharmaceutical's other long-term assets for the quarter that ended in Mar. 2024 was ¥669.4 Mil.

Chongqing Lummy Pharmaceutical's quarterly other long-term assets increased from Sep. 2023 (¥652.2 Mil) to Dec. 2023 (¥712.8 Mil) but then stayed the same from Dec. 2023 (¥712.8 Mil) to Mar. 2024 (¥669.4 Mil).

Chongqing Lummy Pharmaceutical's annual other long-term assets increased from Dec. 2021 (¥597.8 Mil) to Dec. 2022 (¥696.7 Mil) and increased from Dec. 2022 (¥696.7 Mil) to Dec. 2023 (¥712.8 Mil).

Chongqing Lummy Pharmaceutical Other Long Term Assets Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Other Long Term Assets Chart

Chongqing Lummy Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 713.07 718.82 597.84 696.68 712.80

Chongqing Lummy Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 638.86 651.12 652.17 712.80 669.37

Chongqing Lummy Pharmaceutical Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Chongqing Lummy Pharmaceutical (SZSE:300006) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Other Long Term Assets
Comparable Companies
SZSE:301281 SHSE:600613 SZSE:002198 SZSE:001367 SZSE:000705 SZSE:000952 SZSE:000908 SZSE:000411 SZSE:300109 SHSE:688176 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Website
http://www.cqlummy.com
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical (SZSE:300006) Headlines

No Headlines